Deliver Biosciences
Pre-clinicalDeliver Biosciences is building a nanoparticle-based delivery platform to genetically engineer cells inside patients to create scalable, affordable and potent cell and gene therapies.
Founded
2021
Focus
RNA TherapeuticsDrug Delivery
About
Deliver Biosciences is building a nanoparticle-based delivery platform to genetically engineer cells inside patients to create scalable, affordable and potent cell and gene therapies.
Funding History
1Total raised: $3M
Seed$3MUndisclosedFeb 15, 2023
Company Info
TypePrivate
Founded2021
LocationCambridge, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile